Sponsors

Lead Sponsor

Forest Laboratories

This study will include three phases: screening, treatment and follow-up. Screening: this phase will last a maximum of 15 days and subjects eligibility will be evaluated after informed consent signature. Urea breath test (UBT) will be performed in addition to routine baseline evaluations (physical, lab test, etc). Treatment: subjects will be treated for 10 days. A "confirmation of eligibility" visit will take place on Day 0 and an "end-of-treatment" visit will take place between days 9-14. Follow-up: approximately one month post-treatment, eradication of H. pylori will be confirmed through UBT

Related studies

RECRUITINGPhase 4

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

NCT07179159 · HELICOBACTER PYLORI INFECTIONS

RECRUITINGPhase 2

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

NCT07293910 · HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, and more

View all related studies →

Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication

Effect of PPIs on Stool DNA Test for H. Pylori

Registry for the Management of Helicobacter Pylori Infection in Shandong Province

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Trial snapshot

Condition

Locations shown

For caregivers